![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 6620 |
FusionGeneSummary for CDKL2_CXCL11 |
![]() |
Fusion gene information | Fusion gene name: CDKL2_CXCL11 | Fusion gene ID: 6620 | Hgene | Tgene | Gene symbol | CDKL2 | CXCL11 | Gene ID | 8999 | 6373 |
Gene name | cyclin dependent kinase like 2 | C-X-C motif chemokine ligand 11 | |
Synonyms | KKIAMRE|P56 | H174|I-TAC|IP-9|IP9|SCYB11|SCYB9B|b-R1 | |
Cytomap | 4q21.1 | 4q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | cyclin-dependent kinase-like 2CDC2-related kinasep56 KKIAMRE protein kinaseprotein kinase p56 KKIAMREserine/threonine protein kinase KKIAMREtesticular tissue protein Li 35 | C-X-C motif chemokine 11beta-R1chemokine (C-X-C motif) ligand 11interferon gamma-inducible protein 9interferon-inducible T-cell alpha chemoattractantsmall inducible cytokine B11small inducible cytokine subfamily B (Cys-X-Cys), member 11small induci | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q92772 | O14625 | |
Ensembl transtripts involved in fusion gene | ENST00000429927, ENST00000307465, | ENST00000306621, ENST00000503860, | |
Fusion gene scores | * DoF score | 3 X 2 X 2=12 | 4 X 1 X 4=16 |
# samples | 3 | 4 | |
** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/16*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: CDKL2 [Title/Abstract] AND CXCL11 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CXCL11 | GO:0006935 | chemotaxis | 12782716 |
Tgene | CXCL11 | GO:0030816 | positive regulation of cAMP metabolic process | 12782716 |
Tgene | CXCL11 | GO:0043950 | positive regulation of cAMP-mediated signaling | 12782716 |
Tgene | CXCL11 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 12782716 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LUAD | TCGA-55-7914-01A | CDKL2 | chr4 | 76551005 | - | CXCL11 | chr4 | 76957217 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000429927 | ENST00000306621 | CDKL2 | chr4 | 76551005 | - | CXCL11 | chr4 | 76957217 | - |
5CDS-5UTR | ENST00000429927 | ENST00000503860 | CDKL2 | chr4 | 76551005 | - | CXCL11 | chr4 | 76957217 | - |
5CDS-5UTR | ENST00000307465 | ENST00000306621 | CDKL2 | chr4 | 76551005 | - | CXCL11 | chr4 | 76957217 | - |
5CDS-5UTR | ENST00000307465 | ENST00000503860 | CDKL2 | chr4 | 76551005 | - | CXCL11 | chr4 | 76957217 | - |
Top |
FusionProtFeatures for CDKL2_CXCL11 |
![]() |
Hgene | Tgene |
CDKL2 | CXCL11 |
Chemotactic for interleukin-activated T-cells but notunstimulated T-cells, neutrophils or monocytes. Induces calciumrelease in activated T-cells. Binds to CXCR3. May play animportant role in CNS diseases which involve T-cell recruitment.May play a role in skin immune responses. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CDKL2_CXCL11 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CDKL2_CXCL11 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CDKL2 | APP, FRY, HSP90AA1, HSP90AA5P, HSP90AA4P, CDC37, CDK14 | CXCL11 | CXCR3, MTUS2, SMARCB1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CDKL2_CXCL11 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CDKL2_CXCL11 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDKL2 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | CDKL2 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | CDKL2 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | CXCL11 | C0282488 | Interstitial Cystitis | 1 | CTD_human |